Kuros Bioscience (CSBTF, $24.41) was a top loser over the last three months, falling -1 to $24.41 per share. A.I.dvisor analyzed 412 stocks in the Medical Specialties Industry for the 3-month period ending February 13, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.